Ranking of factors influencing the effectiveness of epilepsy treatment in children

dc.contributor.authorSukhonosova, O.Yu.
dc.contributor.authorLitovchenko, T.A.
dc.date.accessioned2026-11-19T09:04:03Z
dc.date.issued2026
dc.description.abstractPurpose: To evaluate the effectiveness of antiepileptic therapy in children with epilepsy and to identify anamnestic, clinical, aetiological, and neurophysiological factors associated with pharmacoresistant seizure courses. Method: A total of 1,017 children aged 3 months to 18 years receiving antiepileptic drugs were examined. Patients were divided into two groups: those with controlled seizures (n = 762; 74.93 ± 1.36%) and uncontrolled seizures (n = 255; 25.07 ± 1.36%). Management followed International League Against Epilepsy (ILAE) standards and the Ukrainian national unified clinical protocol. Comparative analyses included epilepsy form, aetiology, localisation, seizure characteristics, perinatal history, neurological and somatic status, psychomotor development, EEG, and MRI findings. Variation statistics were applied using ranking procedures and Pearson contingency coefficients (С) to determine associations between treatment effectiveness and clinical variables. Results: Pharmacoresistant epilepsy was most strongly associated with symptomatic forms (83.53%), significantly exceeding the controlled group. Epileptic encephalopathies also showed notable representation. Key etiological contributors included perinatal injury (50.70%), congenital brain malformations (23.47%), and multifocal localisation (47.06%). Uncontrolled seizures were characterised by high frequency (70.20%), multiple seizure types (57.65%), generalised and serial seizures (54.51%). Strong associations with poor control were found for seizure manifestations and frequency (C up to 0.54). Adverse perinatal factors included complicated pregnancies (83.14%), intrauterine hypoxia (34.12%), low Apgar scores (≤6). Neurological deficits (92.55%), somatic pathology (84.71%), and psychomotor delay (82.75%) predominated in the uncontrolled group. Neurophysiological data showed combined EEG abnormalities in 82.75% and combined MRI changes in 49.41%, both markedly higher than in controlled patients. EEG correlations with treatment resistance were strong (C up to 0.66–0.69). Conclusion: Pharmacoresistant epilepsy in children is multifactorial and strongly linked to symptomatic aetiology, perinatal CNS damage, multifocal brain involvement, severe seizure patterns, developmental impairment, and combined EEG/MRI abnormalities. Early identification of these predictors may improve prognosis, guide individualised therapy, and optimise long-term seizure control strategies.
dc.identifier.citationSukhonosova O, Litovchenko T. Ranking of factors influencing the effectiveness of epilepsy treatment in children. In: 16th European Epilepsy Congress: Abstracts book; 2026 Sept 5-9; Athens, Greece. [Place unknown]; 2026. p. 616.
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/39012
dc.language.isoen
dc.subjectpharmacoresistant epilepsy
dc.subjectepileptic encephalopathies
dc.subjectEEG
dc.subject2026а
dc.titleRanking of factors influencing the effectiveness of epilepsy treatment in children
dc.typeTheses

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
eec_2026_abstract_book_01_09_with_cover-1 (2).pdf
Size:
404.38 KB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
2.69 KB
Format:
Item-specific license agreed upon to submission
Description: